OxThera (private company)

See something wrong or missing? Let us know
Offices:
Stockholm
Category:
Biotech Pharma
Business model:
B2B

Total investments received (USD) - 83.05M

Loading...

OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria.

OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria, and enzymes. Oxabact® holds Orphan Drug designations in Europe and in the US for the treatment of primary hyperoxaluria.

Companies with similar profile to OxThera:

You need an account to access this feature. Login or create one from here.

News about OxThera (5)